+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levodopa"

From
Lewy Body Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Lewy Body Disease - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 80 Pages
  • Global
From
Parkinson's Disease Pipeline Analysis Report 2026 - Product Thumbnail Image

Parkinson's Disease Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 150 Pages
  • Global
From
From
Parkinson's Disease Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Parkinson's Disease Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Dementia with Lewy Bodies Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Dementia with Lewy Bodies Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Parkinsons Disease (Pd) Drugs Market 2026-2030 - Product Thumbnail Image

Parkinsons Disease (Pd) Drugs Market 2026-2030

  • Report
  • June 2026
  • 302 Pages
  • Global
From
From
From
From
From
Transdermal CNS Therapeutics to 2028 - Product Thumbnail Image

Transdermal CNS Therapeutics to 2028

  • Report
  • July 2023
  • 115 Pages
  • Global
From
From
Entacapone API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Entacapone API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
From
Opicapone Capsules Market - Global Forecast 2025-2030 - Product Thumbnail Image

Opicapone Capsules Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Loading Indicator

Levodopa is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a dopamine precursor, meaning it is converted into dopamine in the brain, which helps to reduce the symptoms of Parkinson's. Levodopa is usually taken in combination with other drugs, such as carbidopa, to increase its effectiveness. It is one of the most commonly prescribed drugs for Parkinson's, and is often the first line of treatment. Levodopa is a part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological disorders. The CNS drug market is highly competitive, with many different companies offering various treatments. Some of the companies in the Levodopa market include Merck, Novartis, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more